Goldman Sachs
CGEN icon

Goldman Sachs’s Compugen CGEN Stock Holding History

Goldman Sachs’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$125K Sell
58,576
-13,432
-19% -$26.1K ﹤0.01% 6178
2025
Q4 		$110K Sell
72,008
-299
-0.4% -$496 ﹤0.01% 6174
2025
Q3 		$106K Sell
72,307
-15,204
-17% -$22.6K ﹤0.01% 6069
2025
Q2 		$156K Buy
87,511
+29,243
+50% +$43.4K ﹤0.01% 5725
2025
Q1 		$85.1K Sell
58,268
-288,232
-83% -$563K ﹤0.01% 5819
2024
Q4 		$530K Sell
346,500
-485
-0.1% -$789 ﹤0.01% 5222
2024
Q3 		$628K Sell
346,985
-136,942
-28% -$250K ﹤0.01% 4922
2024
Q2 		$813K Buy
483,927
+376,984
+353% +$785K ﹤0.01% 4540
2024
Q1 		$276K Sell
106,943
-10,509
-9% -$24.5K ﹤0.01% 5010
2023
Q4 		$233K Sell
117,452
-173,356
-60% -$151K ﹤0.01% 5099
2023
Q3 		$270K Sell
290,808
-32,395
-10% -$35.6K ﹤0.01% 4939
2023
Q2 		$368K Buy
323,203
+53,558
+20% +$46.7K ﹤0.01% 4902
2023
Q1 		$189K Buy
269,645
+234,658
+671% +$193K ﹤0.01% 5318
2022
Q4 		$25K Sell
34,987
-148,470
-81% -$130K ﹤0.01% 5679
2022
Q3 		$121K Buy
183,457
+74,181
+68% +$105K ﹤0.01% 5636
2022
Q2 		$202K Sell
109,276
-114,054
-51% -$246K ﹤0.01% 5631
2022
Q1 		$719K Buy
223,330
+81,999
+58% +$277K ﹤0.01% 5089
2021
Q4 		$608K Buy
141,331
+18,695
+15% +$101K ﹤0.01% 5241
2021
Q3 		$732K Sell
122,636
-41,875
-25% -$280K ﹤0.01% 4963
2021
Q2 		$1.36M Sell
164,511
-165,941
-50% -$1.35M ﹤0.01% 4531
2021
Q1 		$2.84M Buy
330,452
+178,873
+118% +$1.98M ﹤0.01% 3637
2020
Q4 		$1.84M Sell
151,579
-23,336
-13% -$322K ﹤0.01% 3788
2020
Q3 		$2.84M Buy
174,915
+66,406
+61% +$1.09M ﹤0.01% 3321
2020
Q2 		$1.63M Buy
108,509
+84,121
+345% +$1.14M ﹤0.01% 3596
2020
Q1 		$177K Sell
24,388
-19,943
-45% -$157K ﹤0.01% 4748
2019
Q4 		$264K Buy
+44,331
New +$228K ﹤0.01% 4795
2019
Q3 		– Sell
-175,720
Closed -$675K – 5181
2019
Q2 		$675K Buy
+175,720
New +$622K ﹤0.01% 4245
2018
Q2 		– Sell
-47,906
Closed -$213K – 5685
2018
Q1 		$213K Buy
47,906
+31,513
+192% +$106K ﹤0.01% 4968
2017
Q4 		$41K Sell
16,393
-8,148
-33% -$24.2K ﹤0.01% 5977
2017
Q3 		$93K Sell
24,541
-3,483
-12% -$12.1K ﹤0.01% 6083
2017
Q2 		$106K Sell
28,024
-31,773
-53% -$132K ﹤0.01% 6097
2017
Q1 		$257K Buy
59,797
+16,696
+39% +$77.1K ﹤0.01% 5566
2016
Q4 		$220K Buy
43,101
+25,254
+142% +$151K ﹤0.01% 5697
2016
Q3 		$112K Buy
17,847
+3,217
+22% +$21.8K ﹤0.01% 6171
2016
Q2 		$95K Buy
14,630
+1,183
+9% +$7.89K ﹤0.01% 6153
2016
Q1 		$75K Buy
13,447
+2,418
+22% +$12.6K ﹤0.01% 6229
2015
Q4 		$70K Sell
11,029
-11,056
-50% -$72.5K ﹤0.01% 6373
2015
Q3 		$114K Sell
22,085
-7,207
-25% -$42K ﹤0.01% 6408
2015
Q2 		$203K Sell
29,292
-1,652
-5% -$11.6K ﹤0.01% 6139
2015
Q1 		$218K Sell
30,944
-29,375
-49% -$240K ﹤0.01% 5945
2014
Q4 		$502K Buy
60,319
+43,828
+266% +$337K ﹤0.01% 5271
2014
Q3 		$141K Sell
16,491
-6,027
-27% -$53.5K ﹤0.01% 6409
2014
Q2 		$202K Sell
22,518
-772
-3% -$6.94K ﹤0.01% 6195
2014
Q1 		$245K Buy
23,290
+1,115
+5% +$12.3K ﹤0.01% 5902
2013
Q4 		$198K Buy
22,175
+235
+1% +$2.3K ﹤0.01% 5965
2013
Q3 		$225K Buy
+21,940
New +$171K ﹤0.01% 5775

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Goldman Sachs's CGEN Position: Q1 2026 in Review

Goldman Sachs reduced its Compugen (CGEN) stake by 19% in Q1 2026, selling an estimated $26.1K and leaving 58,576 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #6178.

Goldman Sachs first reported a position in CGEN in Q3 2013 and has held it in 46 quarters since. The position peaked at $2.84M in Q3 2020. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • Goldman Sachs held 58,576 shares of Compugen worth $125K as of Q1 2026.
  • Goldman Sachs sold 13,432 Compugen shares in Q1 2026, an estimated $26.1K.
  • Compugen made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6178 holding.
  • Goldman Sachs first reported a position in Compugen in Q3 2013 and has held it in 46 quarters since.
  • Goldman Sachs's Compugen position peaked at $2.84M in Q3 2020.
  • 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.